AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Episode 17. Acquired Aplastic Anemia
Blood Cancer Talks
The Role of JAC1-2 in the Treatment of Plastic Anemia
There are ongoing investigations in a fairly recent publication looking specifically at JAC1-2 inhibitors. I think as someone who treats MPNs with some regularity, my concern is Ruxilitinib is incredibly mild-suppressive in those patients. So I think we'll have to explore further what makes sense if this is a viable treatment.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode